Similar articles for PMID: 21994342

Year	Number of Results
2005	1
2006	9
2007	8
2008	12
2009	11
2010	14
2011	18
2012	11
2013	6
2014	13
2015	7
2016	3
2018	1
2019	1
2020	1
2023	1
2024	1

1

Varenicline dose dependently enhances responding for nonpharmacological reinforcers and attenuates the reinforcement-enhancing effects of nicotine.

Levin ME, Weaver MT, Palmatier MI, Caggiula AR, Sved AF, Donny EC. Levin ME, et al. Nicotine Tob Res. 2012 Mar;14(3):299-305. doi: 10.1093/ntr/ntr213. Epub 2011 Oct 12. Nicotine Tob Res. 2012. PMID: 21994342 Free PMC article.

2

Differentiating the primary reinforcing and reinforcement-enhancing effects of varenicline.

Schassburger RL, Levin ME, Weaver MT, Palmatier MI, Caggiula AR, Donny EC, Sved AF. Schassburger RL, et al. Psychopharmacology (Berl). 2015 Mar;232(5):975-83. doi: 10.1007/s00213-014-3732-x. Epub 2014 Sep 12. Psychopharmacology (Berl). 2015. PMID: 25209677 Free PMC article.

3

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE. Garrison GD, et al. Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Clin Ther. 2009. PMID: 19393839 Review.

4

The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats.

Paterson NE, Min W, Hackett A, Lowe D, Hanania T, Caldarone B, Ghavami A. Paterson NE, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Dec 1;34(8):1455-64. doi: 10.1016/j.pnpbp.2010.07.037. Epub 2010 Aug 11. Prog Neuropsychopharmacol Biol Psychiatry. 2010. PMID: 20708056

5

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T. Cahill K, et al. Cochrane Database Syst Rev. 2012 Apr 18;(4):CD006103. doi: 10.1002/14651858.CD006103.pub6. Cochrane Database Syst Rev. 2012. PMID: 22513936 Updated. Review.

6

Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brain.

Hussmann GP, DeDominicis KE, Turner JR, Yasuda RP, Klehm J, Forcelli PA, Xiao Y, Richardson JR, Sahibzada N, Wolfe BB, Lindstrom J, Blendy JA, Kellar KJ. Hussmann GP, et al. J Neurochem. 2014 May;129(4):721-31. doi: 10.1111/jnc.12653. Epub 2014 Feb 7. J Neurochem. 2014. PMID: 24422997 Free PMC article.

7

Effects of chronic varenicline treatment on nicotine, cocaine, and concurrent nicotine+cocaine self-administration.

Mello NK, Fivel PA, Kohut SJ, Carroll FI. Mello NK, et al. Neuropsychopharmacology. 2014 Apr;39(5):1222-31. doi: 10.1038/npp.2013.325. Epub 2013 Nov 22. Neuropsychopharmacology. 2014. PMID: 24304823 Free PMC article.

8

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T. Cahill K, et al. Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Cochrane Database Syst Rev. 2011. PMID: 21328282 Updated. Review.

9

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T. Cahill K, et al. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006103. doi: 10.1002/14651858.CD006103.pub4. Cochrane Database Syst Rev. 2010. PMID: 21154363 Updated. Review.

10

Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans.

Sofuoglu M, Herman AI, Mooney M, Waters AJ. Sofuoglu M, et al. Psychopharmacology (Berl). 2009 Nov;207(1):153-62. doi: 10.1007/s00213-009-1643-z. Epub 2009 Aug 20. Psychopharmacology (Berl). 2009. PMID: 19693492 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year